BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28904183)

  • 1. The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.
    Rosenthal A; Gabrielian A; Engle E; Hurt DE; Alexandru S; Crudu V; Sergueev E; Kirichenko V; Lapitskii V; Snezhko E; Kovalev V; Astrovko A; Skrahina A; Taaffe J; Harris M; Long A; Wollenberg K; Akhundova I; Ismayilova S; Skrahin A; Mammadbayov E; Gadirova H; Abuzarov R; Seyfaddinova M; Avaliani Z; Strambu I; Zaharia D; Muntean A; Ghita E; Bogdan M; Mindru R; Spinu V; Sora A; Ene C; Vashakidze S; Shubladze N; Nanava U; Tuzikov A; Tartakovsky M
    J Clin Microbiol; 2017 Nov; 55(11):3267-3282. PubMed ID: 28904183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TB DEPOT (Data Exploration Portal): A multi-domain tuberculosis data analysis resource.
    Gabrielian A; Engle E; Harris M; Wollenberg K; Juarez-Espinosa O; Glogowski A; Long A; Patti L; Hurt DE; Rosenthal A; Tartakovsky M
    PLoS One; 2019; 14(5):e0217410. PubMed ID: 31120982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of genomic variability for drug-resistant strains of Mycobacterium tuberculosis: The special case of Belarus.
    Gabrielian A; Engle E; Harris M; Wollenberg K; Glogowski A; Long A; Hurt DE; Rosenthal A
    Infect Genet Evol; 2020 Mar; 78():104137. PubMed ID: 31838261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
    Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
    Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis - A global emergency: Tools and methods to monitor, understand, and control the epidemic with specific example of the Beijing lineage.
    Couvin D; Rastogi N
    Tuberculosis (Edinb); 2015 Jun; 95 Suppl 1():S177-89. PubMed ID: 25797613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status.
    Wollenberg K; Harris M; Gabrielian A; Ciobanu N; Chesov D; Long A; Taaffe J; Hurt D; Rosenthal A; Tartakovsky M; Crudu V
    BMC Infect Dis; 2020 Jan; 20(1):17. PubMed ID: 31910804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China.
    Wang XH; Ma AG; Han XX; Gu XM; Fu LP; Li PG; Li FY; Wang QZ; Liang H; Katar A; Wang LJ
    Med Sci Monit; 2015 May; 21():1313-8. PubMed ID: 25950148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
    Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK
    PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time.
    Dalal A; Pawaskar A; Das M; Desai R; Prabhudesai P; Chhajed P; Rajan S; Reddy D; Babu S; Jayalakshmi TK; Saranchuk P; Rodrigues C; Isaakidis P
    PLoS One; 2015; 10(1):e0116798. PubMed ID: 25606853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
    Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
    Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
    Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
    Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Said HM; Kock MM; Ismail NA; Mphahlele M; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    J Clin Microbiol; 2012 Sep; 50(9):2857-62. PubMed ID: 22649019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the frequency of mutation genes in multidrug-resistant tuberculosis (MDR-TB) strains in Beijing, China.
    Liu Y; Sun Y; Zhang X; Zhang Z; Xing Q; Ren W; Yao C; Yu J; Ding B; Wang S; Li C
    Epidemiol Infect; 2021 Jan; 149():e21. PubMed ID: 33397543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
    PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa.
    Lanzas F; Karakousis PC; Sacchettini JC; Ioerger TR
    J Clin Microbiol; 2013 Oct; 51(10):3277-85. PubMed ID: 23884993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of Mycobacterium tuberculosis drug susceptibility testing and genotyping with epidemiological data analysis to gain insight into the epidemiology of drug-resistant tuberculosis in Malatya, Turkey.
    Agarwal M; Gunal S; Durmaz R; Yang Z
    J Clin Microbiol; 2010 Sep; 48(9):3301-5. PubMed ID: 20660214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
    Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS
    Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.